News results

Showing 51 - 60 of 1554 results

Drugs for Rare Diseases – Nova Scotia Agreement

| Health Canada | backgrounders

Today, the Governments of Canada and Nova Scotia signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $39 million over three years to improve access to new drugs for rare diseases for Nova Scotia residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.


Government of Canada signs pharmacare agreement with Yukon to improve universal access to free medications

| Health Canada | news releases

Today, Member of Parliament Brendan Hanley, on behalf of the Honourable Kamal Khera, Canada’s Minister of Health, and the Honourable Tracy-Anne McPhee, Yukon’s Minister of Health and Social Services, announced the signing of a pharmacare agreement to invest up to $9.5 million over four years to provide universal access to contraceptive and diabetes medications for residents of Yukon. The funding from this agreement will also improve access to diabetes devices and supplies.


Drugs for Rare Diseases – Yukon Agreement Backgrounder

| Health Canada | backgrounders

Today, the Government of Canada and the territory of Yukon signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $8.5 million over three years to improve access to new drugs for rare diseases for residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.


Drugs for Rare Diseases - Northwest Territories Agreement 

| Health Canada | backgrounders

Today, the Governments of Canada and Northwest Territories signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $7.8 million over three years to improve access to new drugs for rare diseases for residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.


Drugs for Rare Diseases - Nunavut Agreement

| Health Canada | backgrounders

Today, the Governments of Canada and Nunavut signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $7.3 million over three years to improve access to new drugs for rare diseases for residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.


Government of Canada signs bilateral agreement with Nunavut for Drugs for Rare Diseases

| Health Canada | news releases

Today, the Honourable Mark Holland, Canada’s Minister of Health, and the Honourable John Main, Nunavut’s Minister of Health, announced a bilateral agreement investing over $7.3 million over three years to improve access to selected new drugs for rare diseases, and to support enhanced access to existing drugs, early diagnosis, and screening.


Government of Canada signs bilateral agreement with Northwest Territories for Drugs for Rare Diseases

| Health Canada | news releases

Today, the Honourable Mark Holland, Canada’s Minister of Health, and the Honourable Lesa Semmler, Northwest Territories’ Minister of Health and Social Services, announced a bilateral agreement investing over $7.8 million to improve access to selected new drugs for rare diseases, and to support enhanced access to existing drugs, early diagnosis, and screening.


Government of Canada signs bilateral agreement with Yukon for Drugs for Rare Diseases

| Health Canada | news releases

Today, the Honourable Mark Holland, Canada’s Minister of Health and the Honourable Tracy-Anne McPhee, Yukon’s Minister of Health and Social Services, announced a bilateral agreement investing over $8.5 million over three years to improve access to selected new drugs for rare disease and to support enhanced access to existing drugs, early diagnosis and screening.


Drugs for Rare Diseases — Prince Edward Island Agreement

| Health Canada | backgrounders

Today, the Governments of Canada and the province of Prince Edward Island (PEI) signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $10 million over three years to improve access to new drugs for rare diseases for PEI residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.


Page details

2017-05-26